-+ 0.00%
-+ 0.00%
-+ 0.00%

Sensorion names Fred Chereau CEO, effective June 1, 2026

PUBT·05/18/2026 05:30:23
Listen to the news
Sensorion names Fred Chereau CEO, effective June 1, 2026
  • Sensorion named Fred Chereau chief executive officer, effective June 1, 2026.
  • Chereau joins from Alexion - AstraZeneca Rare Disease, where he was senior vice president for strategy and business development; he previously led LogicBio Therapeutics as president and CEO until its 2022 sale to Alexion.
  • Amit Munshi will remain chairman, ending his stint as interim CEO that began in February 2026.
  • Chief Medical Officer Géraldine Honnet will step down to join a privately held biotechnology company.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sensorion SA published the original content used to generate this news brief via Business Wire (Ref. ID: 202605180130BIZWIRE_USPR_____20260517_BW653003) on May 18, 2026, and is solely responsible for the information contained therein.